Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

Blood. 2022 Nov 17;140(20):2175-2179. doi: 10.1182/blood.2022017015.

Kai Rejeski^{1

2

3}, Zhijie Wu⁴, Viktoria Blumenberg^{1

2

3}, Wolfgang G Kunz⁵, Susanna Müller⁶, Sachiko Kajigaya⁴, Shouguo Gao⁴, Veit L Bücklein^{1

2}, Lisa Frölich^{1

3}, Christian Schmidt¹, Michael von Bergwelt-Baildon^{1

3}, Xingmin Feng⁴, Neal S Young⁴, Marion Subklewe^{1

2

3}

¹ Department of Medicine III, Hematology/Oncology, University Hospital, Ludwig-Maximilians Universität (LMU) Munich, Munich, Germany.
² Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
³ German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany.
⁴ Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
⁵ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
⁶ Department of Pathology, University Hospital, LMU Munich, Munich, Germany.

No abstract available

MeSH terms